CANCER THERAPY AND GENES
ANCHOR LEAD: EVEN AS THE US SUPREME COURT IS CONSIDERING A GENETIC TEST RELATED TO CANCER, MORE ARE BEING DEVELOPED, ELIZABETH TRACEY REPORTS
Whether the ability to test for certain genetic defects related to cancer can be patented is a case the US Supreme Court probably can’t decide fast enough, as such tests with very important predictive ability clinically are being developed apace. One new test at Johns Hopkins assesses treatment of brain cancers and looks very promising. William Nelson, director of the Kimmel Cancer Center at Johns Hopkins, says these tests are the future.
NELSON: I do think the technology is advancing so rapidly that the ability to do this, and this is one of the first examples, is the ability to get a lot of information about all the many, many gene defects in an individual’s cancer, and to turn that information into ways to help people select treatments, help monitor the effectiveness of treatment. I think this is a good first example of where our whole cancer medicine is headed. :26
At Johns Hopkins, I’m Elizabeth Tracey.